Let's spread the word about Immunotherapy! Click to share this page with your community.

2020 Frontiers in Cancer Immunotherapy

This annual two-day meeting convenes top experts in tumor immunology, cancer genetics and computational biology to discuss innovative methods to analyze both the tumor and the host immune system and highlight the links between tumor genotype, immune phenotype and patient response. Key topics under discussion this year include tumor evolution, neoantigens, novel therapeutic targets, and mechanisms driving the emergence of resistance to current therapy.


  • Elizabeth Jaffee, M.D., Johns Hopkins School of Medicine
  • Elaine Mardis, Ph.D., The Ohio State University
  • Robert Schreiber, Ph.D., Washington University School of Medicine in St. Louis
  • Charles Swanton, FRCP, Ph.D., FRS, The Francis Crick Institute
  • Catherine Wu, M.D., Dana-Farber Cancer Institute and Harvard Medical School


REGISTER: nyas.org/Immunotherapy2020

Early Bird Discount Ends: March 30, 2020

May 11-12, 2020, at the New York Academy of Sciences in New York City

*Immunotherapy results may vary from patient to patient.